Kinetic Benefit(s) of Allosteric Receptor Blockade by Positive Allosteric Modulator Antagonists
ACS Pharmacology & Translational Science · 14.08.2026 · 9 (8) · 1994-2007
DOI: 10.1021/acsptsci.6c00324 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 29.07.2026. Verfasst von Georges Vauquellin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This paper discusses how targeted pharmacologic experiments can elucidate the mechanism of allosteric receptor inhibitors (NAMs) to identify NAMs that may have exceptionally useful properties and target residence times in vivo. Specifically, experiments can be done to identify positive allosteric modulator (PAM) antagonists, NAMs that increase the affinity of the receptor for the agonist but decrease agonist efficacy. These molecules would be predicted to have long receptor offset times in vivo (in the presence of ambient concentrations of agonist) and favorable receptor residence times for therapy and also selectively target agonist prebound receptors. Flux analysis is used to demonstrate the salient properties of PAM antagonists and their favorable pharmacodynamic effects for blocking physiological signals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium.
- Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7365, United States.
ORCID-Profile: Georges Vauquellin, Terry Kenakin
Zitieren
APA
Vauquellin, G., & Kenakin, T. (2026). Kinetic Benefit(s) of Allosteric Receptor Blockade by Positive Allosteric Modulator Antagonists. ACS Pharmacology & Translational Science, 9(8), 1994-2007. https://doi.org/10.1021/acsptsci.6c00324
Vancouver
Vauquellin G, Kenakin T. Kinetic Benefit(s) of Allosteric Receptor Blockade by Positive Allosteric Modulator Antagonists. ACS Pharmacology & Translational Science. 2026;9(8):1994-2007. doi:10.1021/acsptsci.6c00324
BibTeX
@article{Vauquellin2026,
author = {Vauquellin, Georges and Kenakin, Terry},
title = {Kinetic Benefit(s) of Allosteric Receptor Blockade by Positive Allosteric Modulator Antagonists},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {8},
pages = {1994--2007},
doi = {10.1021/acsptsci.6c00324}
}
EUVIMED